Status:
COMPLETED
The California Home Abortion by Telehealth (CHAT) Study
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
California Latinas for Reproductive Justice
UCGHI Center for Gender and Health Justice Center of Expertise
Conditions:
Abortion Early
Eligibility:
FEMALE
13+ years
Brief Summary
This study aims to assess efficacy and safety outcomes of a telehealth model of abortion care. The study will compare efficacy of this model to usual in-clinic care based on published rates. It will a...
Detailed Description
There are 2 components to the study: 1. A clinical records review on all patients 2. A survey study on a subset of patients who agree to participate. Clinical Records Review: We will examine medical...
Eligibility Criteria
Inclusion
- Current patient of a participating telehealth platform for medication abortion (includes ages 13-64 years)
- Able to read and write in English or Spanish
- Willing to participate in enrollment survey and two follow-up surveys
Exclusion
- Not a current patient of a participating telehealth platform for medication abortion
- Unable to read or write in English or Spanish
- Unwilling to participate in study surveys
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
6020 Patients enrolled
Trial Details
Trial ID
NCT04432792
Start Date
May 1 2021
End Date
June 30 2022
Last Update
February 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Advancing New Standards in Reproductive Health (ANSIRH)
San Francisco, California, United States, 94612